30 studies found for:    " August 01, 2012":" August 31, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults
Intervention: Drug: Antibody UB-421
22 Completed Preliminary Evaluation of a Point-Of-Care Liver Function Test
Conditions: HIV;   Tuberculosis;   Drug-Induced Liver Injury
Intervention: Device: Diagnostics for All liver function test (LFT)
23 Recruiting Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
24 Recruiting HIV Reverse Cholesterol Transport Study
Conditions: HIV;   Dyslipidemia
Intervention:
25 Active, not recruiting ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment
Condition: HIV
Intervention: Other: Tenofovir Dose Adjustment
26 Not yet recruiting Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
27 Not yet recruiting Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
28 Completed Acceptability of Depo-subQ in Uniject
Condition: Contraception
Intervention:
29 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib
30 Completed Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
Condition: Tuberculosis
Intervention: Biological: GSK Biologicals' investigational TB vaccine GSK 692342

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years